![]() Electronic activity monitoring devices have the potential to offer positive health-related opportunities to patients however their introduction to the healthcare setting is not without difficulty. The potential ability of electronic activity monitoring systems to provide an objective, accurate measurement of patient functional performance is explored. This paper reviews the past, present, and potential future of functional performance status assessment in an oncology setting. Despite these limitations important clinical decisions are based on PS including eligibility for clinical trials, the “optimal” therapeutic approach in routine practice, and the allocation of healthcare resources. ![]() However, these scales are subjective, subject to bias and high interobserver variability. These standard assessment tools have been shown to correlate with response to chemotherapy, chemotherapy tolerability, survival, and quality of life of cancer patients. ![]() Oncologists rely upon measurement instruments of functional performance such as the Karnofsky or Eastern Cooperative Oncology Group Performance Status scales that were developed over fifty years ago to determine a patient's suitability for systemic treatment. ![]() Progress in cancer research is coupled with increased treatment complexity reliant upon accurate patient selection. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |